Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
PMV Pharmaceuticals, Inc. (PMVP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.2% stake in PMV PHARMACEUTICALS, INC. |
| 05/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 1.4% stake in EXIT FILING PMV PHARMACEUTICALS INC |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 6.9% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 3% stake in PMV Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 3.8% stake in PMV Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6% stake in PMV Pharmaceuticals Inc. |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in PMV PHARMACEUTICALS, INC. |
| 01/25/2023 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 8.7% stake in PMV PHARMACEUTICALS, INC. |
| 01/24/2023 |
SC 13G/A
| Cowen Financial Products LLC reports a 3.3% stake in PMV Pharmaceuticals, Inc. |
| 07/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 3.9% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 6.3% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Nextech V Oncology S.C.S., SICAV-SIF reports a 3.1% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Euclidean Capital LLC reports a 5.1% stake in PMV PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 7.2% stake in PMV Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 3.2% stake in PMV Pharmaceuticals, Inc. |
| 10/18/2021 |
SC 13G/A
| Euclidean Capital LLC reports a 5.4% stake in PMV PHARMACEUTICALS, INC. |
| 05/07/2021 |
SC 13G/A
| Euclidean Capital LLC reports a 10.4% stake in PMV PHARMACEUTICALS, INC. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|